Open AccessTrefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies
Author(s) -
Piotr Eder,
Kamila StawczykEder,
Katarzyna Korybalska,
Natasza Czepulis,
Jacek Łuczak,
Liliana ŁykowskaSzuber,
Iwona KrelaKaźmierczak,
Krzysztof Linke,
Janusz Witowski
Publication year - 2017
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v23.i1.135
Subject(s) - calprotectin , crohn's disease , erythrocyte sedimentation rate , medicine , tumor necrosis factor alpha , antibody , trefoil , gastroenterology , fibrinogen , immunology , ulcerative colitis , orosomucoid , c reactive protein , intestinal mucosa , pathology , inflammation , inflammatory bowel disease , disease , biology , glycoprotein , microbiology and biotechnology , agronomy
To evaluate whether repeated serum measurements of trefoil factor-3 (TFF-3) can reliably reflect mucosal healing (MH) in Crohn's disease (CD) patients treated with anti-tumor necrosis factor-α (anti-TNF-α) antibodies.